{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T10:04:25Z","timestamp":1760954665461,"version":"3.40.5"},"reference-count":22,"publisher":"American Academy of Pediatrics (AAP)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2003,1,1]]},"abstract":"<jats:p>Objective. Hepatitis C virus (HCV) infection is the leading cause of liver failure in adulthood. Although the prevalence of HCV is reportedly as high as 80% in incarcerated adult populations, little is known about the prevalence of HCV in incarcerated juvenile populations. The purpose of this study was to determine the prevalence of HCV and high-risk behaviors in a population of incarcerated youths.<\/jats:p>\n               <jats:p>Methods. We conducted a cross-sectional prevalence study of HCV infection in youths who were admitted to a juvenile detention center between September 1999 and January 2001. Subjects were asked questions regarding behaviors that might put them at risk for acquiring HCV, and blood was drawn for HCV antibody testing. Qualitative HCV RNA testing was performed on antibody-positive subjects.<\/jats:p>\n               <jats:p>Results. Seventy-four percent (n = 305) of youths consented to participate in the seroprevalence study. HCV risk behaviors were common in this population: sexual activity (70%), intravenous drug use (6%), intranasal drug use (32%), body piercing (53%), and tattoos (33%). Six study youths (2%) were HCV antibody positive; 4 of these subjects were also HCV RNA positive. HCV-positive status was significantly associated with history of intravenous drug use and having had a sexually transmitted disease. Only 17% of study participants could correctly identify behaviors that might put them at risk for HCV.<\/jats:p>\n               <jats:p>Conclusions. The prevalence of HCV in incarcerated youths is higher than in the general pediatric population but not yet at adult levels of prevalence. Given the high prevalence of risk factors in this population, future studies should address the need for targeted HCV screening and education of incarcerated youths regarding risks for HCV.<\/jats:p>","DOI":"10.1542\/peds.111.1.153","type":"journal-article","created":{"date-parts":[[2004,8,14]],"date-time":"2004-08-14T00:43:47Z","timestamp":1092444227000},"page":"153-157","source":"Crossref","is-referenced-by-count":44,"title":["Prevalence of Hepatitis C Virus Infection and Risk Factors in an Incarcerated Juvenile Population: A Pilot Study"],"prefix":"10.1542","volume":"111","author":[{"given":"Karen F.","family":"Murray","sequence":"first","affiliation":[{"name":"Hepatobiliary Program, Division of Gastroenterology and Nutrition, Department of Pediatrics, Children\u2019s Hospital and Regional Medical Center, Seattle, Washington"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura P.","family":"Richardson","sequence":"additional","affiliation":[{"name":"Child Health Institute, University of Washington, Seattle, Washington"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chihiro","family":"Morishima","sequence":"additional","affiliation":[{"name":"Viral Hepatitis Clinical Research Laboratory, Virology Division, Department of Laboratory Medicine, Harborview Medical Center and University of Washington, Seattle, Washington"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James W. M.","family":"Owens","sequence":"additional","affiliation":[{"name":"Echo Glen Children\u2019s Center, Seattle, Washington"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David R.","family":"Gretch","sequence":"additional","affiliation":[{"name":"Viral Hepatitis Clinical Research Laboratory, Virology Division, Department of Laboratory Medicine, Harborview Medical Center and University of Washington, Seattle, Washington"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"417","published-online":{"date-parts":[[2003,1,1]]},"reference":[{"key":"2021120821092412700_R1","doi-asserted-by":"crossref","unstructured":"Alter HJ, Conry-Cantilena C, Melpolder J, et al. Hepatitis C in asymptomatic blood donors. Hepatology.1997;26(suppl 1):29S\u201333S","DOI":"10.1002\/hep.510260705"},{"key":"2021120821092412700_R2","doi-asserted-by":"crossref","unstructured":"Alter MJ. Hepatitis C virus infection in the United States. J Hepatol.1999;31(suppl 1):88\u201391","DOI":"10.1016\/S0168-8278(99)80381-X"},{"key":"2021120821092412700_R3","doi-asserted-by":"crossref","unstructured":"Williams I. Epidemiology of hepatitis C in the United States. Am J Med.1999;107:2S\u20139S","DOI":"10.1016\/S0002-9343(99)00373-3"},{"key":"2021120821092412700_R4","doi-asserted-by":"crossref","unstructured":"Samuel MC, Doherty PM, Bulterys M, Jenison SA. Association between heroin use, needle sharing and tattoos received in prison with hepatitis B and C positivity among street-recruited injecting drug users in New Mexico, USA. Epidemiol Infect.2001;127:475\u2013484","DOI":"10.1017\/S0950268801006197"},{"key":"2021120821092412700_R5","doi-asserted-by":"crossref","unstructured":"Kann L, Kinchen SA, Williams BI, et al. Youth Risk Behavior Surveillance-United States, 1999. State and local YRBSS Coordinators. J Sch Health.2000;70:271\u2013285","DOI":"10.1111\/j.1746-1561.2000.tb07252.x"},{"key":"2021120821092412700_R6","doi-asserted-by":"crossref","unstructured":"Jonas MM, Robertson LM, Middleman AB. Low prevalence of antibody to hepatitis C virus in an urban adolescent population. J Pediatr.1997;131:314\u2013316","DOI":"10.1016\/S0022-3476(97)70174-4"},{"key":"2021120821092412700_R7","doi-asserted-by":"crossref","unstructured":"Morris RE, Harrison EA, Knox GW, et al. Health risk behavioral survey from 39 juvenile correctional facilities in the United States. J Adolesc Health.1995;17:334\u2013344","DOI":"10.1016\/1054-139X(95)00098-D"},{"key":"2021120821092412700_R8","doi-asserted-by":"crossref","unstructured":"Ogilvie EL, Veit F, Crofts N, Thompson SC. Hepatitis infection among adolescents resident in Melbourne Juvenile Justice Centre: risk factors and challenges. J Adolesc Health.1999;25:46\u201351","DOI":"10.1016\/S1054-139X(98)00086-X"},{"key":"2021120821092412700_R9","doi-asserted-by":"crossref","unstructured":"Lee SC, Antony A, Lee N, et al. Improved version 2.0 qualitative and quantitative Amplicor reverse transcription-PCR tests for hepatitis C virus RNA: calibration to international units, enhanced genotype reactivity, and performance characteristics. J Clin Microbiol.2000;38:4171\u20134179","DOI":"10.1128\/JCM.38.11.4171-4179.2000"},{"key":"2021120821092412700_R10","doi-asserted-by":"crossref","unstructured":"Garfein RS, Vlahov D, Galai N, Doherty MC, Nelson KE. Viral infections in short-term injection drug users: the prevalence of the hepatitis C, hepatitis B, human immunodeficiency, and human T-lymphotropic viruses. Am J Public Health.1996;86:655\u2013661","DOI":"10.2105\/AJPH.86.5.655"},{"key":"2021120821092412700_R11","doi-asserted-by":"crossref","unstructured":"Garfein RS, Doherty MC, Monterroso ER, et al. Prevalence and incidence of hepatitis C virus infection among young adult injection drug users. J Acquir Immune Defic Syndr Hum Retrovirol.1998;18:S11\u2013S19","DOI":"10.1097\/00042560-199802001-00004"},{"key":"2021120821092412700_R12","doi-asserted-by":"crossref","unstructured":"Girardi E, Zaccarelli M, Tossini G, et al. Hepatitis C virus infection in intravenous drug users: prevalence and risk factors. Scand J Infect Dis.1990;22:751\u2013752","DOI":"10.3109\/00365549009027133"},{"key":"2021120821092412700_R13","doi-asserted-by":"crossref","unstructured":"Spaulding A, Greene C, Davidson K, Schneidermann M, Rich J. Hepatitis C in state correctional facilities. Prev Med.1999;28:92\u2013100","DOI":"10.1006\/pmed.1998.0418"},{"key":"2021120821092412700_R14","doi-asserted-by":"crossref","unstructured":"Thomas DL, Vlahov D, Solomon L, et al. Correlates of hepatitis C virus infections among injection drug users. Medicine (Baltimore).1995;74:212\u2013220","DOI":"10.1097\/00005792-199507000-00005"},{"key":"2021120821092412700_R15","doi-asserted-by":"crossref","unstructured":"Grant BF, Dawson DA. Age of onset of drug use and its association with DSM-IV drug abuse and dependence: results from the National Longitudinal Alcohol Epidemiologic Survey. J Subst Abuse.1998;10:163\u2013173","DOI":"10.1016\/S0899-3289(99)80131-X"},{"key":"2021120821092412700_R16","doi-asserted-by":"crossref","unstructured":"Conry-Cantilena C, VanRaden M, Gibble J, et al. Routes of infection, viremia, and liver disease in blood donors found to have hepatitis C virus infection. N Engl J Med.1996;334:1691\u20131696","DOI":"10.1056\/NEJM199606273342602"},{"key":"2021120821092412700_R17","doi-asserted-by":"crossref","unstructured":"Sanchez-Quijano A, Rey C, Aguado I, et al. Hepatitis C virus infection in sexually promiscuous groups. Eur J Clin Microbiol Infect Dis.1990;9:610\u2013612","DOI":"10.1007\/BF01967218"},{"key":"2021120821092412700_R18","unstructured":"Beck A, Shipley B. Special Report: Recidivism of Young Parolees. Bureau of Justice Statistics. Washington, DC: US Department of Justice, Office of Justice Programs; 1987"},{"key":"2021120821092412700_R19","unstructured":"Redlinger TE, O\u2019Rourke K, Magana J, Steege A. Hepatitis B and C among adolescents at an STD clinic on the US-Mexico border. Tex Med.2001;97:52\u201356"},{"key":"2021120821092412700_R20","doi-asserted-by":"crossref","unstructured":"Noell J, Rohde P, Ochs L, et al. Incidence and prevalence of chlamydia, herpes, and viral hepatitis in a homeless adolescent population. Sex Transm Dis.2001;28:4\u201310","DOI":"10.1097\/00007435-200101000-00003"},{"key":"2021120821092412700_R21","unstructured":"Roy E, Haley N, Leclerc P, et al. Risk factors for hepatitis C virus infection among street youths. Can Med Assoc J.2001;165:557\u2013560"},{"key":"2021120821092412700_R22","doi-asserted-by":"crossref","unstructured":"Hahn JA, Page-Shafer K, Lum PJ, Ochoa K, Moss AR. Hepatitis C virus infection and needle exchange use among young injection drug users in San Francisco. Hepatology.2001;34:180\u2013187","DOI":"10.1053\/jhep.2001.25759"}],"container-title":["Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/111\/1\/153\/1005876\/pe0103000153.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/111\/1\/153\/1005876\/pe0103000153.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,9]],"date-time":"2021-12-09T01:09:22Z","timestamp":1639012162000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.aap.org\/pediatrics\/article\/111\/1\/153\/28515\/Prevalence-of-Hepatitis-C-Virus-Infection-and-Risk"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,1,1]]},"references-count":22,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2003,1,1]]},"published-print":{"date-parts":[[2003,1,1]]}},"URL":"https:\/\/doi.org\/10.1542\/peds.111.1.153","relation":{},"ISSN":["0031-4005","1098-4275"],"issn-type":[{"type":"print","value":"0031-4005"},{"type":"electronic","value":"1098-4275"}],"subject":[],"published":{"date-parts":[[2003,1,1]]}}}